The 9th International Conference on Alzheimer’s Disease & Related Disorders, held from 18 to 20 April at Khalifa University, gathered clinicians, researchers, neuroscientists, and healthcare professionals to discuss the latest advances in dementia research, diagnosis, and care strategies.
As an Exhibitor, the National Reference Laboratory (NRL) showcased its Neurobiochemical Diagnostics portfolio, featuring advanced biomarker panels including Beta-Amyloid 42/40 Ratio, Total Tau, Phosphorylated Tau (p-Tau), and Neurofilament Light Chain (NfL).
NRL’s presence supported collaborative engagement and reinforced its commitment to advancing early detection and improving clinical decision-making in neurodegenerative disease care.
